Regenerative Medical Technology (RMTG) Market Capitalization (2017 - 2026)
Regenerative Medical Technology (RMTG) posted Market Capitalization of $686948.4 for Q2 2026, up 74.28% on a QoQ basis from $394169.0 in Q1 2026, and up 36.96% year-over-year from $501558.7 in Q2 2025.
Analysis
Regenerative Medical Technology (RMTG) Market Capitalization (2017 - 2026) Analysis & Trends
Regenerative Medical Technology has reported Market Capitalization for 10 years, with the latest figure at $686948.4 in Q2 2026.
- On a quarterly basis, Market Capitalization rose 36.96% year-over-year to $686948.4 in Q2 2026; TTM through Jun 2026 was $686948.4, a 36.96% increase from a year earlier, with the FY2025 full-year figure at $656948.4, up 74.64% from the prior year.
- Market Capitalization was $686948.4 for Q2 2026 at Regenerative Medical Technology, up from $394169.0 in the prior quarter.
- The five-year high for Market Capitalization was $851298.2 in Q1 2022, with the low at $124939.4 in Q4 2023.
- Average Market Capitalization over 5 years is $442410.7, with a median of $385169.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Market Capitalization tumbled 92.37% in 2022, then jumped 201.08% in 2024.
- Over 5 years, Market Capitalization stood at $248878.8 in 2022, then sank by 49.8% to $124939.4 in 2023, then surged by 201.08% to $376169.0 in 2024, then surged by 74.64% to $656948.4 in 2025, then gained by 4.57% to $686948.4 in 2026.
- The last three Market Capitalization figures came in at $686948.4 (Q2 2026), $394169.0 (Q1 2026), and $656948.4 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.78 Bn | 56.40 Mn |
| 10 | Regenerative Medical Technology | 1.18 Mn | -139,694.93 | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 686,948.41 |
| Mar 31, 2026 | 394,169.03 |
| Dec 31, 2025 | 656,948.41 |
| Sep 30, 2025 | 752,338.06 |
| Jun 30, 2025 | 501,558.71 |
| Mar 31, 2025 | 376,169.03 |
| Dec 31, 2024 | 376,169.03 |
| Sep 30, 2024 | 376,169.03 |
| Jun 30, 2024 | 499,757.51 |
| Mar 31, 2024 | 499,757.51 |
| Dec 31, 2023 | 124,939.38 |
| Sep 30, 2023 | 140,462.52 |
| Jun 30, 2023 | 248,878.75 |
| Mar 31, 2023 | 248,878.75 |
| Dec 31, 2022 | 248,878.75 |
| Sep 30, 2022 | 367,526.63 |
| Jun 30, 2022 | 612,544.41 |
| Mar 31, 2022 | 851,298.21 |
| Dec 31, 2021 | 3.26 Mn |
| Sep 30, 2021 | 1.08 Mn |